MoneyWorks4Me

Cohance Lifesciences - Quaterly Results

13 Aug 2025 Evaluate
The revenue declined to Rs. 4835.80 millions for the quarter ended June 2025 as compared to Rs. 4880.80 millions during the corresponding quarter last year.The Net Profit of the company slipped to Rs. 525.70 millions from Rs. 754.50 millions, a decline of -30.32% on QoQ basis.The Operating Profit of the company witnessed a decrease to 1173.00 millions from 1445.80 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 4835.80 4880.80 -0.92 4835.80 4880.80 -0.92 10935.10 10513.50 4.01
Other Income 131.00 194.10 -32.51 131.00 194.10 -32.51 539.80 566.10 -4.65
PBIDT 1173.00 1445.80 -18.87 1173.00 1445.80 -18.87 4165.50 4624.70 -9.93
Interest 68.00 102.00 -33.33 68.00 102.00 -33.33 80.00 74.50 7.38
PBDT 1024.00 1343.80 -23.80 1024.00 1343.80 -23.80 4085.50 4550.20 -10.21
Depreciation 313.60 312.80 0.26 313.60 312.80 0.26 572.00 546.00 4.76
PBT 710.40 1031.00 -31.10 710.40 1031.00 -31.10 3513.50 4004.20 -12.25
TAX 184.70 276.50 -33.20 184.70 276.50 -33.20 796.40 1039.50 -23.39
Deferred Tax 3.20 8.90 -64.04 3.20 8.90 -64.04 -127.30 65.90 -293.17
PAT 525.70 754.50 -30.32 525.70 754.50 -30.32 2717.10 2964.70 -8.35
Equity 382.60 254.60 50.27 382.60 254.60 50.27 254.60 254.60 0.00
PBIDTM(%) 24.26 29.62 -18.11 24.26 29.62 -18.11 38.09 43.99 -13.40
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..